An implantable brain-machine interface system for hand movement compensation developed by a Shanghai company has become the ...
“We are very pleased with the positive response we received during MEDICAL JAPAN OSAKA 2026,” said a spokesperson for Cearvol. “The exhibition provided a valuable opportunity to present our upcoming ...
San Jose (California, USA), March 16, 2026: L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leader in AI, ...
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
In this prominent people in packaging interview, Paul Marshall from Zimmer Biomet reflects on balancing innovation and patient safety.
The application of artificial intelligence (AI) in drug discovery is revolutionizing the field, offering unprecedented opportunities for accelerating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results